聚燦光電(300708.SZ)收到全資子公司聚燦宿遷2024年度分紅款1.22億元
格隆匯2月25日丨聚燦光電(300708.SZ)公佈,公司近日收到全資子公司聚燦光電科技(宿遷)有限公司(以下簡稱"聚燦宿遷")2024年度分紅款12,214.23萬元。
聚燦宿遷爲公司納入合併報表範圍內全資子公司,公司持有其100%的股份,根據其公司章程並經股東決定,經容誠會計師事務所(特殊普通合夥)審計,以截至2024年12月31日財務報告未分配利潤爲基數,向公司派發現金股利12,214.23萬元。
上述利潤分配將增加公司2025年度母公司報表淨利潤,但不增加公司2025年度合併報表淨利潤,因此,不會影響2025年度公司整體經營業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.